Carcell is a global biotech company empowering drug delivery through red cell therapeutics and lipid nanoparticles (LNPs). As a fellow biotech company, we understand the intricacies of making and developing a drug. As such, we offer a variety of licensing opportunities, research collaborations and contract services depending on your needs to bring your preclinical pipelines all the way to the finish line.

Carcell has a rapidly growing vault of > 1,500 novel and proprietary ionizable lipids. We test the potency and distribution of these lipids in mice and compare them to commercial benchmarks such as ALC-0315, SM-102 and MC3. The top performers are subjected to further scrutiny such as tolerability studies and freedom-to-operate (FTO) analysis. Some of these lipids are available for licensing (with or without co-development).

Carcell also has a suite of end-to-end LNP services for your experimental needs. Our LNP services include:
1. Lipid synthesis
2. Lipid screening (pre-curated or customized panels)
3. LNP formulation
4. LNP optimization
5. In vivo testing of LNP
6. Toxicological evaluation of LNP

Contact us to find out more!